Apellis to Present Safety and Efficacy Data from Clinical Trials of APL-2 in PNH at December Scientific Meetings
November 21, 2016 08:00 ET
|
Apellis Pharmaceuticals, Inc.
LOUISVILLE, Ky., Nov. 21, 2016 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on inhibition of the complement system, announced today it will...
Geron Announces Presentations at American Society of Hematology Annual Meeting
November 03, 2016 09:12 ET
|
Geron Corporation
MENLO PARK, Calif., Nov. 03, 2016 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today announced that four abstracts related to the imetelstat program have been accepted for presentation at...
Geron Announces December Conference Presentation Webcasts
November 30, 2015 07:30 ET
|
Geron Corporation
MENLO PARK, Calif., Nov. 30, 2015 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today announced that John A. Scarlett, M.D., President and Chief Executive Officer, is scheduled to present...
Geron Announces Presentations at American Society of Hematology Annual Meeting
November 05, 2015 09:03 ET
|
Geron Corporation
MENLO PARK, Calif., Nov. 05, 2015 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today announced that three abstracts describing clinical and non-clinical data on imetelstat have been...